0001104659-21-113876.txt : 20210908
0001104659-21-113876.hdr.sgml : 20210908
20210908172725
ACCESSION NUMBER: 0001104659-21-113876
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210906
FILED AS OF DATE: 20210908
DATE AS OF CHANGE: 20210908
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schroeder Theodore R
CENTRAL INDEX KEY: 0001378690
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37558
FILM NUMBER: 211243002
MAIL ADDRESS:
STREET 1: 12481 HIGH BLUFF DRIVE, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nabriva Therapeutics plc
CENTRAL INDEX KEY: 0001641640
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 56 FITZWILLIAM SQUARE
CITY: DUBLIN
STATE: L2
ZIP: 2
BUSINESS PHONE: (610) 816-6640
MAIL ADDRESS:
STREET 1: 1000 CONTINENTAL DRIVE
STREET 2: SUITE 600
CITY: KING OF PRUSSIA
STATE: PA
ZIP: 19406
FORMER COMPANY:
FORMER CONFORMED NAME: Nabriva Therapeutics AG
DATE OF NAME CHANGE: 20150507
4
1
tm2123911d16_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-09-06
0
0001641640
Nabriva Therapeutics plc
NBRV
0001378690
Schroeder Theodore R
414 COMMERCE DR.
SUITE 120
FORT WASHINGTON
PA
19034
1
1
0
0
Chief Executive Officer
Ordinary Shares
2021-09-06
4
F
0
225
1.11
D
176875
D
These ordinary shares were withheld by the Issuer in order to satisfy tax withholding obligations upon the vesting of certain restricted share units.
/s/ Theodore R. Schroeder
2021-09-08